Evaluation of the Efficacy and Safety of Interleucin-2 Combined With PD-1 Monoclonal Antibody in Preoperative Neoadjuvant Therapy for MSS Locally Advanced Rectal Cancer - a Multicenter, Single-arm, Open-label Clinical Trail

Conditions: MSS Locally Advanced Rectal Cancer Interventions: Drug: Sintilimab with Interleukin-2 Sponsors: The First Affiliated Hospital with Nanjing Medical University Not yet recruiting

https://clinicaltrials.gov/study/NCT06108596

Source: ClinicalTrials.gov - October 31, 2023 Category: Research Source Type: clinical trials